$ALUR Q4 '24 Earnings Results & Recap
Q4 '24 EPS of -$7.95 (vs. -$5.70 estimated) and revenue of $5.6M (vs. $5.82M estimated). Despite this, 2025 revenue is projected at approximately $30M, driven by new commercial strategies, and the combination therapy shows strong potential.